Anti – Inflammatory and Analgesics « Go Back
  • INFLAGESIC PLUS
  • INFLAGESIC GEL
  • SUPERGESIC
  • Qualitative & Quantitative Composition.

    Each uncoated tablet contains Aceclofenac I.P. 100 mg and Paracetamol I.P. 500 mg
  • Dosage Form

    Oral Tablets
  • Therapeutic indications

    Anti- inflammatory, Analgesic and Antipyretic.
  • Dosage and administration

    The recommended dose of Inflagesic Plus is 1 tablet twice daily. Generally, no dose adjustment is necessary in elderly patients and those with mild renal impairment. Safety and efficacy has not been established in children.
    As directed by physician
  • Contra-indications

    Patients sensitive to Aceclofenac, Paracetamol or to any of the excipients of the product. Patients in whom aspirin or other NSAIDs, precipitate attacks of bronchospasm, acute rhinitis or urticaria or patients hypersensitive to these drugs.
    Patients with active or suspected peptic ulcer or gastrointestinal bleeding or bleeding disorders.
    Patients with severe heart failure, hypertension, hepatic or renal insufficiency.
    Third trimester of pregnancy.
  • Warnings and Precautions

    Inflagesic Plus may cause dizziness. Driving or operating machinery are to be avoided. Individuals receiving long-term treatment should be regularly monitored for renal function tests, liver function tests and blood counts. It is to be used with caution in hepatic porphyria, coagulation disorders, history of peptic ulcers, ulcerative colitis, Crohn's disease, SLE, cerebrovascular bleeding, pregnancy and lactation. Caution should be exercised in patients with mild to moderate impairment of cardiac, hepatic or renal function and in elderly patients who are more likely to be suffering from these conditions. Caution is also required in patients on diuretic therapy or otherwise at risk of hypovolemia.
  • Drug interactions

    Drug interactions associated with Aceclofenac are similar to those observed with other NSAIDs. Aceclofenac may increase the plasma concentrations of lithium, digoxin and methotrexate. It may increase the activity of anticoagulants, inhibit the activity of diuretics, enhance cyclosporine nehrotoxicity and precipitate convulsions when coadministered with quinolone antibiotics.Coadministration of Aceclofenac with other NSAIDs and corticosteroids are to be avoided due to increased incidence of side-effects.
    The risk of Paracetamol toxicity may be increased in patients receiving other potentially heatotoxic drugs or drugs that induce hepatic microsomal enzymes. Coadministration of Paracetamol with rifampicin, isoniazid, chloramphenicol, anti-epileptic drugs and antiviral drugs is to be avoided. Metoclopromide may increase the absorption of Paracetamol whereas excretion and plasma concentration may be altered when coadministered with probenecid. Cholestyramine also reduces the absorption of Paracetamol.
  • Pregnancy & lactation

    Regular use of Inflagesic Plus during pregnancy and lactation should be avoided, unless the potential benefits outweigh the risks.
  • Undesirable effects/side effects

    Most of the adverse events are minor and reversible with treatment discontinuation. The majority of side effects are related to gastrointestinal system (dyspepsia, abdominal pain, nausea and diarrhea), most frequent being dyspepsia, abdominal pain and rise in hepatic enzymes. Other rare side-effects include dizziness, constipation, vomiting, ulcerative stomatitis, rash, dermatitis, headache, fatigue, allergic reactions, anemia, ranulocytopenia, thrombocytopenia, neutropenia,oedema, palpitation, leg cramps, flushing, purpura, paraesthesia, tremors, gastrointestinal bleeding, gastrointestinal ulceration, pancreatitis, interstitial nephritis, depression, abnormal dreaming, somnolence, insomnia, vasculitis, hypoglycemia, rise in blood urea, serum creatinine and serum potassium. As with other NSAIDs, severe mucocutaneous skin reactions may occur.
  • Overdose

    Overdosage may cause nausea, vomiting, pain abdomen, dizziness, somnolence, headache, sweating, pancreatitis, hepatic failure and acute renal failure.
  • Qualitative & Quantitative Composition.

    Aceclofenac I.P. 1.5% w/w, Oleum Lini 3.0% w/w (containing alpha linolenic acid), Methyl salicylate I.P. 10.0% w/w, Menthol I.P. 5.0%w/w, and Benzyl alcohol B.P. 1.0% w/w (As preservative)
    In a gel base.
  • Dosage Form

    Topical Gel.
  • Therapeutic indications

    Anti inflammatory & analgesic.
  • Dosage and administration

    Inflagesic gel should be applied to the affected area 3-4 times per day, however it may vary depending on the size of the affected area and response.
    As directed by physician
  • Warnings and Precautions

    Inflagesic Gel should not be used in the following conditions:
    When a person having hypersensitivity towards any of the ingredient.
    Where skin is broken.
    On skin infection sites like eczema, blisters, and other skin problem.
  • Undesirable effects/side effects

    Inflagesic Gel is well tolerated and safe medication for the effective management of inflammatory and painful conditions.
  • Qualitative & Quantitative Composition.

    Katuvira 0.3% w/w, Gandhapuro tel 11.6% w/w, Laung ka tel 2.1% w/w, Pudina sat 8.7% w/w, and Karpoor 4.3% w/w. In a cream base.
  • Dosage Form

    Topical Cream.
  • Therapeutic indications

    Anti inflammatory & analgesic.
  • Dosage and administration

    Apply ½ inch cream (depending upon size of affected area) 2-3 times daily to the affected and spread gently. Do not rub.
  • Warnings and Precautions

    Do not apply inside the nostrilis or eyes or anywhere on the face and neck or on open wounds. Discontinue use if irritation persists. Not advocated for children.
  • Undesirable effects/side effects

    Rarely may cause hypersensitive reactions.